跳转至内容
Merck
CN

07076

聚氧乙烯氢化蓖麻油

别名:

PEG-40蓖麻油, 氢化蓖麻油® RH 40, 聚乙二醇甘油羟基硬脂酸酯, 聚氧乙烯40氢化蓖麻油

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

化学文摘社编号:
UNSPSC Code:
12161900
NACRES:
NA.25
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

impurities

≤0.2% sulfated ash (verfied on random samples only), ≤1 ppm ethylene oxide, ≤10 ppm dioxan, ≤10 ppm heavy metals (verfied on random samples only), ≤2 ppm arsenic (verfied on random samples only), ≤2.0% water, ≤5000 ppm acetic acid, ≤620 ppm diethylene glycol, ≤620 ppm ethylene glycol

ign. residue

≤0.25% (verfied onrandom samples only)

acid value

≤0.8 mg KOH/g

hydroxyl value

60‑75 mg KOH/g

iodine value

≤1.0 g I2/100 g

saponification value

50‑60 mg KOH/g

suitability

suitable for acidity or alkalinity

Application

聚氧乙烯氢化蓖麻油可用于溶解维生素、水不溶性活性物质、以及溶于水或水和醇混合物的精油。

Analysis Note

凝固温度16-26°C

Other Notes

聚氧乙烯氢化蓖麻油是一系列非离子聚乙氧基化去污剂的品牌名称。它被开发用作增溶剂和乳化剂。

Legal Information

Cremophor is a registered trademark of BASF SE


存储类别

11 - Combustible Solids

flash_point_f

467.6 °F

flash_point_c

242 °C

法规信息

植物油/植物胶产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Christofori M R R Nastiti et al.
Pharmaceutics, 12(2) (2020-02-06)
Resveratrol (RSV) is a potent lipophilic antioxidant with a low aqueous solubility. Novel nanoformulations have been successfully developed and evaluated to increase the potential of resveratrol as a skin targeting antioxidant. Nanoformulations were prepared using a spontaneous emulsification method, and
Ming-Kung Yeh et al.
AAPS PharmSciTech, 10(1), 166-171 (2009-02-19)
The formulation study of tenoxicam, a poorly water-soluble drug, was developed by use of a ternary cosolvent system and has significantly enhanced the solubility. Additionally, the relative bioavailability of testing formulation was also evaluated by New Zealand rabbit with a
Hong-Tao Song et al.
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 31(17), 1413-1417 (2006-11-08)
To prepare a sustained-release formulation of traditional Chinese medicine compound recipe by adopting time-controlled release techniques. Shuxiong tablets were chosen as model drug. The prescription and technique of core tablets were formulated with selecting disintegrating time and swelling volume of



全球贸易项目编号

货号GTIN
07076-1KG04061832684826